Uscom Ltd - Asset Resilience Ratio
Uscom Ltd (UCM) has an Asset Resilience Ratio of 29.76% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Uscom Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Uscom Ltd's Asset Resilience Ratio has changed over time. See Uscom Ltd (UCM) net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Uscom Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Uscom Ltd worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$966.66K | 29.76% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$966.66K | 29.76% |
Asset Resilience Insights
- Very High Liquidity: Uscom Ltd maintains exceptional liquid asset reserves at 29.76% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Uscom Ltd Industry Peers by Asset Resilience Ratio
Compare Uscom Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 8.60% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 9.40% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Ok Biotech Co Ltd
TW:4155 |
Medical Devices | 0.32% |
|
Promimic AB
ST:PRO |
Medical Devices | 8.62% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Annual Asset Resilience Ratio for Uscom Ltd (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Uscom Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 57.37% | AU$2.95 Million ≈ $2.08 Million |
AU$5.13 Million ≈ $3.63 Million |
+45.79pp |
| 2023-06-30 | 11.58% | AU$600.00K ≈ $424.54K |
AU$5.18 Million ≈ $3.67 Million |
-63.86pp |
| 2022-06-30 | 75.45% | AU$6.03 Million ≈ $4.27 Million |
AU$7.99 Million ≈ $5.66 Million |
+74.88pp |
| 2021-06-30 | 0.57% | AU$30.43K ≈ $21.53K |
AU$5.33 Million ≈ $3.77 Million |
+0.06pp |
| 2020-06-30 | 0.51% | AU$30.40K ≈ $21.51K |
AU$5.92 Million ≈ $4.19 Million |
-29.05pp |
| 2019-06-30 | 29.56% | AU$1.22 Million ≈ $865.77K |
AU$4.14 Million ≈ $2.93 Million |
-16.82pp |
| 2018-06-30 | 46.39% | AU$2.49 Million ≈ $1.76 Million |
AU$5.38 Million ≈ $3.80 Million |
+8.38pp |
| 2017-06-30 | 38.01% | AU$1.71 Million ≈ $1.21 Million |
AU$4.49 Million ≈ $3.17 Million |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$5.71 Million ≈ $4.04 Million |
-- |
About Uscom Ltd
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure w… Read more